Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1988 1
1991 1
1992 1
1994 2
1995 3
1996 4
1997 4
1998 4
1999 7
2000 2
2001 4
2002 5
2003 4
2004 2
2005 1
2007 1
2008 1
2011 1
2012 1
2013 1
2017 1
2021 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
[Clinical Practice guidelines for the use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin bêta, darbepoetin) in anaemic patients with cancer: 2007 update (summary report)].
Ray-Coquard I, Kassab-Chahmi D, Casadevall N, Chastagner P, Marchal C, Marec-Bérard P, Misset JL; Standards, Options et Recommandations (SOR); Institut National du Cancer; Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC); Ligue contre le Cancer pour la Vie; Fédération Hospitalière de France; Fédération Nationale de Cancérologiedes Centres Hospitaliers Regionaux et Universitaires (FNCHRU); Fédération Française de Cancérologie; Union Nationale Hospitalière Privée de Cancérologie (UNHPC). Ray-Coquard I, et al. Bull Cancer. 2008 Apr;95(4):433-41. doi: 10.1684/bdc.2008.0635. Bull Cancer. 2008. PMID: 18495573 Review. French.
[Intensive chemotherapy with autologous stem cell transplantation in ovarian cancers: analysis of 67 patients treated at the Paoli-Calmettes Institute and a review of the literature].
Viens P, Bertucci F, Gravis G, Camerlo J, Cowen D, Delpero JR, Conte M, Jacquemier J, Faucher C, Blaise D, Bardou VJ, Chabannon C, Blanc AP, Jaubert D, Maraninchi D. Viens P, et al. Among authors: camerlo j. Bull Cancer. 1997 Sep;84(9):869-76. Bull Cancer. 1997. PMID: 9435808 Review. French.
The Management of a Comprehensive Cancer Center during the First Six Months of the COVID-19 Pandemic in the South of France: Lessons from the Paoli-Calmettes Institute's Experience.
Blaise D, Berger P, Mokart D, Camerlo J, Fougereau E, Giovannini M, Houvenaeghel G, Turrini O, Chabannon C, Piana G, Brenot-Rossi I, Tallet A, Gonçalves A, Charbonnier A, Vey N, Grossi S, Viens P. Blaise D, et al. Among authors: camerlo j. Clin Hematol Int. 2021 Sep 27;3(4):119-129. doi: 10.2991/chi.k.210919.001. eCollection 2021 Dec. Clin Hematol Int. 2021. PMID: 34938984 Free PMC article.
Docetaxel and radiotherapy and pancreatic cancer.
Viret F, Ychou M, Gonçalves A, Moutardier V, Magnin V, Braud AC, Dubois JB, Bories E, Gravis G, Camerlo J, Genre D, Maraninchi D, Viens P, Giovannini M. Viret F, et al. Among authors: camerlo j. Pancreas. 2003 Oct;27(3):214-9. doi: 10.1097/00006676-200310000-00003. Pancreas. 2003. PMID: 14508124 Clinical Trial.
French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions.
Galambrun C, Pondarré C, Bertrand Y, Loundou A, Bordigoni P, Frange P, Lutz P, Mialou V, Rubie H, Socié G, Schneider P, Bernaudin F, Paillard C, Michel G, Badens C, Thuret I; French Rare Disease Center for Thalassemia; French Society of Bone Marrow Transplantation. Galambrun C, et al. Biol Blood Marrow Transplant. 2013 Jan;19(1):62-8. doi: 10.1016/j.bbmt.2012.08.005. Epub 2012 Aug 11. Biol Blood Marrow Transplant. 2013. PMID: 22892550 Free article. Clinical Trial.
Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy.
Bertucci F, Finetti P, Rougemont J, Charafe-Jauffret E, Nasser V, Loriod B, Camerlo J, Tagett R, Tarpin C, Houvenaeghel G, Nguyen C, Maraninchi D, Jacquemier J, Houlgatte R, Birnbaum D, Viens P. Bertucci F, et al. Among authors: camerlo j. Cancer Res. 2004 Dec 1;64(23):8558-65. doi: 10.1158/0008-5472.CAN-04-2696. Cancer Res. 2004. PMID: 15574762
PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer.
Guerin M, Rezai K, Isambert N, Campone M, Autret A, Pakradouni J, Provansal M, Camerlo J, Sabatier R, Bertucci F, Charafe-Jauffret E, Hervieu A, Extra JM, Viens P, Lokiec F, Boher JM, Gonçalves A. Guerin M, et al. Among authors: camerlo j. Eur J Cancer. 2017 Nov;86:28-36. doi: 10.1016/j.ejca.2017.08.025. Epub 2017 Sep 23. Eur J Cancer. 2017. PMID: 28950146 Clinical Trial.
52 results